Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis in organ transplant recipients: Methods to improve treatment [Fotodynamisk terapi med topikal methyl-aminolevulinat til aktiniske keratoser hos organtransplanterede patienter: Metoder til at optimere behandling]

Trial Profile

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis in organ transplant recipients: Methods to improve treatment [Fotodynamisk terapi med topikal methyl-aminolevulinat til aktiniske keratoser hos organtransplanterede patienter: Metoder til at optimere behandling]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis; Skin cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Nov 2012 Planned number of patients changed from 19 to 15 as reported by European Clinical Trials Database record.
    • 03 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top